News
New Look Eyewear Inc. announces its results for the third quarter of 2014
Monday, November 10 2014 | 00 h 00 min | News
New Look has reported revenues of $32.5 million for the third quarter that ended September 27, 2014.
Read MoreIncreased sales and profits at Hoya
Monday, November 10 2014 | 00 h 00 min | News
Hoya posted an 18.6% increase in its profits for the second quarter of 2014, compared with the same period in 2013.
Read MoreAbbott reports good results in eye care market
Monday, November 10 2014 | 00 h 00 min | News
Abbott reported a sales increase of 5.8% over last year for the third quarter of 2014.
Read MoreMarchand Giguère merges with FYidoctors
Thursday, November 6 2014 | 00 h 00 min | News
As part of its expansion plans, the Calgary-based optometry network, FYidoctors, has made its entry into Quebec by merging with the Marchand Giguère Group.
Read MoreCourt reprimands Valeant and Pershing Square
Wednesday, November 5 2014 | 00 h 00 min | News
A California court says that Allergan raises serious questions as to whether Valeant and Pershing Square engaged in insider trading.
Read More
Sales growth and new appointments at Luxottica
Wednesday, November 5 2014 | 00 h 00 min | News
Luxottica reported sales of CA$8.2 billion for the first nine months of 2014, a 2.1% increase over the same period last year.
Read MoreFear of vision loss
Wednesday, November 5 2014 | 00 h 00 min | Vision Science
People fear blindness as much as they do cancer, Alzheimer’s disease and HIV/AIDS, according to a poll by Research!America and Alliance for Eye and Vision Research.
Read MoreExcellent third quarter for Valeant
Monday, November 3 2014 | 00 h 00 min | News
Quebec-based Valeant Pharmaceuticals, owner of Bausch + Lomb, among others, recorded its second best quarterly results since it was founded in 1960.
Read MoreTough quarter for Johnson & Johnson in the eye care market
Monday, November 3 2014 | 00 h 00 min | News
Despite a good quarter for the company in general (sales of US$18.5 billion, up by 5.1% over last year), Johnson & Johnson reported a drop in eye care product sales in the third quarter of 2014.
Read MoreValeant increases offer for Allergan
Monday, November 3 2014 | 00 h 00 min | News
Quebec-based Valeant Pharmaceuticals has increased its takeover bid for Allergan from US$50 to nearly US$60 billion.
Read More
